packageMigalastat

migalastat

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Migalastat is used to treat Fabry disease. It is authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q161613 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:migalastat
ATC codes:A16AX14
DrugBank:DB05018
PubChem CID:176077
ChEBI:135923
Wikidata:Q161613
formula:C6H13NO4
molar mass:163.173 g/mol (PubChem CID 176077)
logP:-2.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown